1989
DOI: 10.1111/j.1365-2141.1989.tb06283.x
|View full text |Cite
|
Sign up to set email alerts
|

Severe Hb S‐β°‐thalassaemia with a T → C substitution in the donor splice site of the first intron of the β‐globin gene

Abstract: Through direct sequencing and dot-blot analyses with synthetic oligonucleotide probes of amplified DNA, a new nucleotide substitution was discovered in a Black teenager with severe Hb S-beta zero-thalassaemia. The substitution involved a T----C replacement at the second position of the donor splice site of the first intervening sequence of the beta-globin gene. The clinical and haematological observations made in Black subjects with Hb S-beta zero-thalassaemia, with different types of thalassaemia, suggest sev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1991
1991
2001
2001

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 46 publications
(10 citation statements)
references
References 26 publications
0
10
0
Order By: Relevance
“…Although down-regulation of the y-gene at the adult stage is initiated in the absence of a linked 13-globin gene (6) (19) or CACC box mutations (18) argues in favor of a cis-acting mechanism for impaired y-silencing. Since EKLF is present and active at both embryonic and adult stages (16,30), we presume that absence of 03-globin expression at the embryonic stage reflects more effective competition of the 6-and -y-globin genes for the LCR at early times by virtue of their proximity to the LCR and/or a regulatory milieu favoring their expression (8,13,25 (shaded circle) bound to the ,B-globin promoter (hatched box) mediates proteinprotein interactions with the LCR.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although down-regulation of the y-gene at the adult stage is initiated in the absence of a linked 13-globin gene (6) (19) or CACC box mutations (18) argues in favor of a cis-acting mechanism for impaired y-silencing. Since EKLF is present and active at both embryonic and adult stages (16,30), we presume that absence of 03-globin expression at the embryonic stage reflects more effective competition of the 6-and -y-globin genes for the LCR at early times by virtue of their proximity to the LCR and/or a regulatory milieu favoring their expression (8,13,25 (shaded circle) bound to the ,B-globin promoter (hatched box) mediates proteinprotein interactions with the LCR.…”
Section: Discussionmentioning
confidence: 99%
“…We previously proposed a possible role for EKLF during the y-globin to 13-globin switch (16) on the basis of the selective ,B-globin deficiency we observed in EKLF-1-mice and elevated fetal hemoglobin in human adults heterozygous for deletions of the ,B-globin promoter or for mutations in the CACC box of the 13-globin promoter (16)(17)(18)(19). By studying the expression profile of a human globin YAC transgene in EKLF-1-embryos, we demonstrate that EKLF is essential not only for expression of the human f3-globin gene, but also for proper silencing of the human y-globin gene.…”
mentioning
confidence: 99%
“…Sequences and positions of the amplifi cation primers and of the oligonucleotide probes used in the studies are given in table 1. The procedures for amplification and dot-blot analysis are given elsewhere [23][24][25][26], Table 2 lists the results of the hybridization experi ments for 252 ps chromosomes. All 134 |3S chromo somes, previously determined as having haplotype 19, were positive for the G -T substitution at position -657 5' to the AY-globin gene, while all but two were found to be positive for the C -G substitution at posi tion -369 5' to the Gy gene.…”
Section: Methodsmentioning
confidence: 99%
“…There are three possibilities ; translation in these aberrant transcripts is unsuccessful, the translation products from these transcripts are extremely unstable, or the translation products are not recognized by the antibody. In general, a mutation at the second nucleotide of the GT dinucleotide of the 5' splice donor site leads to aberrant splicing [7,[15][16][17]. Such a mutation often produces a transcript which skips the upstream exon or which utilizes a cryptic 5' donor site usually located in the following intron [4,7,171.…”
Section: Discussionmentioning
confidence: 99%